HC Wainwright restated their buy rating on shares of InflaRx (NASDAQ:IFRX – Free Report) in a report published on Friday morning,Benzinga reports. HC Wainwright currently has a $8.00 price target on ...

Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...

The sun has reappeared - rejoice! If resurfaced pigmentation is sparking less joy, this week's Sunday Service has a solution ...

Living with a heart that struggles to pump effectively creates daily challenges for millions of Americans. Systolic heart ...

Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...

High blood pressure, or hypertension, is a common condition that affects millions of people worldwide. To prevent serious ...